Purulent infectious myositis (formerly tropical pyomyositis).
J Neurol Sci
; 413: 116767, 2020 06 15.
Article
en En
| MEDLINE
| ID: mdl-32172014
ABSTRACT
Purulent infectious myositis (PIM), formerly known as tropical pyomyositis, is a pyogenic infection of skeletal muscles. Staphylococcus aureus, a normal human skin inhabitant, is the main pathogen involved, but multiple other microorganisms have been implicated. Although usually a progressive febrile disease with pain in the affected muscle(s), severe, life-threatening forms have been described, especially in immunosuppressed patients and children. PIM may elude early diagnosis given the lack of overlying skin changes. Hence, high index of suspicion followed by imaging modalities (ultrasonography when superficial and computed tomography or magnetic resonance imaging with contrast when deep) help confirm the diagnosis. Treatment requires combination of percutaneous or open surgical drainage along with antimicrobial therapy guided by culture results. The rising incidence of cases due to methicillin-resistant Staphylococcus aureus (MRSA) strains, makes the inclusion of vancomycin be recommended. This paper reviews PIM highlighting its global distribution, causative agents, predisposing factors, management, and potential complications.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Infecciones Estafilocócicas
/
Piomiositis
/
Staphylococcus aureus Resistente a Meticilina
/
Miositis
Tipo de estudio:
Diagnostic_studies
/
Screening_studies
Límite:
Child
/
Humans
Idioma:
En
Año:
2020
Tipo del documento:
Article